Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBT: 2010-2024

Historic EBT for Alkermes (ALKS) over the last 15 years, with Dec 2024 value amounting to $443.8 million.

  • Alkermes' EBT fell 8.60% to $100.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $401.0 million, marking a year-over-year increase of 20.71%. This contributed to the annual value of $443.8 million for FY2024, which is 5.27% up from last year.
  • As of FY2024, Alkermes' EBT stood at $443.8 million, which was up 5.27% from $421.5 million recorded in FY2023.
  • In the past 5 years, Alkermes' EBT registered a high of $443.8 million during FY2024, and its lowest value of -$96.5 million during FY2020.
  • Its 3-year average for EBT is $278.0 million, with a median of $421.5 million in 2023.
  • Its EBT has fluctuated over the past 5 years, first tumbled by 135.48% in 2022, then soared by 1,454.15% in 2023.
  • MRY analysis of 5 years shows Alkermes' EBT stood at -$96.5 million in 2020, then soared by 190.87% to $87.7 million in 2021, then plummeted by 135.48% to -$31.1 million in 2022, then skyrocketed by 1,454.15% to $421.5 million in 2023, then grew by 5.27% to $443.8 million in 2024.
  • Its EBT was $443.8 million in FY2024, compared to $421.5 million in FY2023 and -$31.1 million in FY2022.